A population-wide observational study to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis (TB) and cancer, with those with current or previous TB more likely to have a diagnosis of a variety of cancers, including lung, blood, gynaecological and colorectal cancers.
J&Js Lazcluze/Rybrevant combination obtains European approval to treat NSCLC – Pharmaceutical Technology
Lazcluze and Rybrevant specifically target EGFR mutations that drive tumour growth in certain types of NSCLC. Credit: Sorbetto via Getty Images. Johnson & Johnson’s (J&J)